Peripheral Artery Disease
📧 Sign up to get email alerts when something new happens for Peripheral Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients [Phase 3]
Phase 3 trial update exploring HGF gene therapy for improving angiogenesis and blood perfusion in peripheral artery disease.
-
FDA approval · 2023-06-08FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for a generic clopidogrel product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Texting for Mobility in Overweight/Obese Adults With Peripheral Artery Disease [NA]
Clinical trial update on texting intervention for mobility in adults with overweight/obesity and peripheral artery disease; study completed …
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis [Phase 3]
Phase 3 clinical trial update on paclitaxel-coated balloons for femoral indications to address restenosis in peripheral artery disease was c…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
Clinical trial update for the GORE Drug-Coated PTA Balloon Catheter in peripheral artery disease has completed with results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease [NA]
A completed clinical trial evaluating the combination of telmisartan and exercise to improve functioning in peripheral artery disease.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Optical Imaging Measurement of Intravascular Solution Efficacy Trial [NA]
A completed clinical trial evaluating optical imaging measurement of intravascular solution efficacy in peripheral artery disease with poste…
-
FDA approval · 2022-09-16FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approves a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, pertaining to the approved generic prod…
-
FDA approval · 2022-09-12FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries’ supplemental application for clopidogrel bisulfate, indicating regulatory approval of change…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Directional Versus Orbital Atherectomy Plaque Modification and Luminal Area Assessment of the Femoro-popliteal Artery Via Intravascular Ultrasound [NA]
A completed clinical trial comparing directional versus orbital atherectomy for plaque modification in femoropopliteal arteries with intrava…
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety [Phase 2]
Phase 2 trial evaluating concomitant cilostazol and probucol on biomarkers, endothelial function, and safety in peripheral artery disease.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing ticagrelor to aspirin in patients with peripheral artery disease and type 2 diabetes; results posted after complet…
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Ranger™ and Ranger™ SL (OTW) DCB) in China [NA]
This clinical trial update notes that the Ranger and Ranger SL paclitaxel-coated balloon catheters for femoropopliteal artery lesions in Chi…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: DUAL Pathway Inhibition to Improve Endothelial Function in Peripheral Artery Disease [Phase 4]
Phase 4 clinical trial investigating dual pathway inhibition to improve endothelial function in peripheral artery disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers [Phase 2]
Phase 2 clinical trial update for AMG0001 evaluating improvement in ulcer healing and perfusion in subjects with peripheral ischemic ulcers.
-
FDA approval · 2021-12-21FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited. The action confirms approva…
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Low InTensity Exercise Intervention in PAD [NA]
A completed trial evaluating a low-intensity exercise intervention in peripheral artery disease was conducted and results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study [NA]
Pilot study on orbital vessel preparation to maximize drug-coated balloon efficacy in calcified below-the-knee lesions for peripheral artery…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: TEsting for Arterial Disease in Diabetes (TrEAD) Study
A completed clinical trial investigating arterial disease in diabetes (TrEAD) with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Evaluation of Imaging of Peripheral Arteries by Optical Coherence Tomography and Intravascular Ultrasound Imaging [NA]
A clinical trial evaluating imaging of peripheral arteries using Optical Coherence Tomography and Intravascular Ultrasound in peripheral art…
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol? [Phase 4]
Phase 4 trial updating whether cilostazol can reduce ischemic events in diabetic artery obstruction-related conditions (ischemic stroke and …
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities [Phase 3]
Phase 3 trial updated on the efficacy and safety of rivaroxaban to reduce major thrombotic vascular events in patients with symptomatic peri…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Evaluation of Musculoskeletal Microcirculation With Ultrasound [NA]
A terminated clinical trial evaluating musculoskeletal microcirculation using ultrasound in the context of standardized claudication treadmi…
-
FDA approval · 2020-11-16FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for Cilostazol submitted by Apotex Corp., updating the drug's approval status.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization [NA]
A completed clinical trial update for the Revolution Peripheral Atherectomy System in lower extremity peripheral arterial revascularization;…